SEI Investments
MRNA icon

SEI Investments’s Moderna MRNA Stock Holding History

SEI Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.94M Sell
84,780
-44,615
-34% -$2.31M 0.01% 1408
2026
Q1 		$6.57M Buy
129,395
+55,939
+76% +$2.61M 0.01% 1368
2025
Q4 		$2.17M Sell
73,456
-3,882
-5% -$105K ﹤0.01% 1816
2025
Q3 		$2M Sell
77,338
-23,499
-23% -$656K ﹤0.01% 1696
2025
Q2 		$2.78M Buy
100,837
+32,527
+48% +$857K ﹤0.01% 1516
2025
Q1 		$1.94M Buy
68,310
+6,451
+10% +$229K ﹤0.01% 1647
2024
Q4 		$2.57M Sell
61,859
-8,835
-12% -$422K ﹤0.01% 1586
2024
Q3 		$4.72M Sell
70,694
-6,063
-8% -$557K 0.01% 1314
2024
Q2 		$9.12M Sell
76,757
-8,153
-10% -$1.03M 0.01% 965
2024
Q1 		$9.05M Buy
84,910
+11,977
+16% +$1.21M 0.01% 948
2023
Q4 		$7.25M Sell
72,933
-1,814
-2% -$153K 0.01% 1020
2023
Q3 		$7.72M Sell
74,747
-10,419
-12% -$1.16M 0.01% 968
2023
Q2 		$10.3M Buy
85,166
+13,502
+19% +$1.8M 0.02% 854
2023
Q1 		$11M Buy
71,664
+25,635
+56% +$4.23M 0.02% 784
2022
Q4 		$8.27M Sell
46,029
-6,508
-12% -$1.06M 0.02% 813
2022
Q3 		$6.21M Sell
52,537
-21,407
-29% -$3.25M 0.01% 994
2022
Q2 		$10.5M Buy
73,944
+15,784
+27% +$2.26M 0.02% 757
2022
Q1 		$10M Buy
58,160
+17,031
+41% +$2.87M 0.02% 777
2021
Q4 		$10.5M Sell
41,129
-5,344
-11% -$1.56M 0.02% 771
2021
Q3 		$17.8M Sell
46,473
-17,120
-27% -$6.31M 0.04% 496
2021
Q2 		$14.9M Buy
63,593
+8,890
+16% +$1.59M 0.03% 540
2021
Q1 		$6.98M Buy
54,703
+2,723
+5% +$395K 0.02% 852
2020
Q4 		$5.43M Buy
+51,980
New +$5.26M 0.01% 935
2019
Q2 		– Sell
-1,872
Closed -$21K – 2631
2019
Q1 		$21K Buy
1,872
+1,082
+137% +$20.1K ﹤0.01% 2740
2018
Q4 		$1K Buy
+790
New +$13K ﹤0.01% 2626

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

SEI Investments's MRNA Position: Q2 2026 in Review

SEI Investments reduced its Moderna (MRNA) stake by 34% in Q2 2026, selling an estimated $2.31M and leaving 84,780 shares worth $5.94M. The position accounts for 0.01% of the portfolio, ranked #1408.

SEI Investments first reported a position in MRNA in Q4 2018 and has held it in 25 quarters since. The position peaked at $17.8M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • SEI Investments held 84,780 shares of Moderna worth $5.94M as of Q2 2026.
  • SEI Investments sold 44,615 Moderna shares in Q2 2026, an estimated $2.31M.
  • Moderna made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1408 holding.
  • SEI Investments first reported a position in Moderna in Q4 2018 and has held it in 25 quarters since.
  • SEI Investments's Moderna position peaked at $17.8M in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.